Acute Kidney Injury
A simple risk score could help predict a patient’s susceptibility to cisplatin-associated acute kidney injury (CP-AKI).
Are kidneys from donors who had dialysis more likely to result in adverse outcomes for transplant recipients?
The FDA granted a patent to Unicycive Therapeutics for UNI-494, a drug to treat acute kidney injury (AKI).
Patients with COVID-19–associated AKI seem to have better outcomes than those with AKI related to other respiratory ...
What is the specific impact of acute kidney injury (AKI) on in-hospital mortality among octogenarian patients with COVID-19?
The FDA gave Breakthrough Device designation to the JuxtaFlow RAD to help prevent AKI during cardiothoracic surgery.
Accurate prediction of severe outcomes of acute kidney injury remains challenging.
Opinions differ on the use of no anticoagulation versus regional citrate anticoagulation for treatment of AKI with CKRT.
A baseline creatinine measurement from clinical trial enrollment may not be the best way to detect acute kidney injury.
SGLT-2is are associated with reduced risk of mortality in patients with type 2 diabetes and acute kidney disease.
Patients who have acute kidney injury while hospitalized face increased risk for morbidity and mortality after discharge.
The FDA has granted a Humanitarian Device Exemption Approval Order to the Selective Cytopheretic Device Pediatric.
Advertisement
Advertisement
